HomeMarkets Markets Ozempic is 1,300% more expensive in the U.S. vs the U.K.—so the boss of Novo Nordisk is being hauled in front of Bernie Sanders to explain why By Ilene June 17, 2024 0 177 FacebookTwitterPinterestWhatsApp Now, Novo Nordisk CEO Lars Fruergaard Jørgensen has volunteered to testify to the U.S. Senate to defend the massive markup Americans pay compared to …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected149,450FansLike396,312FollowersFollow2,650SubscribersSubscribe Latest Articles Markets How prepared are the US and its allies for a protracted conflict in Iran? Markets What oil, stocks and bonds are telling us about the Iran conflict and how long it might last Markets Hezbollah − degraded, weakened but not yet disarmed − destabilizes Lebanon once again Markets The Real Reason Trump Went to War Markets 🌋 Weakovering Wednesday: Markets in Crisis: The Hormuz Conflict and Global Volatility Energy What is the Strait of Hormuz, and why does its closure matter so much to the global economy? Hot Items A Plan B for space? On the risks of concentrating national space power in private hands Energy Iran’s targeting of airport, ports and hotels in reaction to US strikes has forced Gulf nations onto front lines of a war – Hot Items Donald Trump has made some bold claims on the US economy. But how do they stack up against the data? Energy ‘Destruction is not the same as political success’: US bombing of Iran shows little evidence of endgame strategy Markets Toppling Tuesday – Regimes and Markets Edition Biotech RFK Jr. Lied His Way Into Office and American Health Is the Victim Markets Putin Is the Iran War’s One Sure Winner Markets Trump Makes Surreal Turn From Talking War to Mocking Melania Load more